CA3235264A1 - Trem compositions and methods of use - Google Patents
Trem compositions and methods of use Download PDFInfo
- Publication number
- CA3235264A1 CA3235264A1 CA3235264A CA3235264A CA3235264A1 CA 3235264 A1 CA3235264 A1 CA 3235264A1 CA 3235264 A CA3235264 A CA 3235264A CA 3235264 A CA3235264 A CA 3235264A CA 3235264 A1 CA3235264 A1 CA 3235264A1
- Authority
- CA
- Canada
- Prior art keywords
- trem
- modification
- naturally occurring
- seq
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- Nanotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163255426P | 2021-10-13 | 2021-10-13 | |
| US202163255420P | 2021-10-13 | 2021-10-13 | |
| US63/255,426 | 2021-10-13 | ||
| US63/255,420 | 2021-10-13 | ||
| US202163284946P | 2021-12-01 | 2021-12-01 | |
| US202163284934P | 2021-12-01 | 2021-12-01 | |
| US63/284,934 | 2021-12-01 | ||
| US63/284,946 | 2021-12-01 | ||
| PCT/US2022/046632 WO2023064513A2 (en) | 2021-10-13 | 2022-10-13 | Trem compositions and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3235264A1 true CA3235264A1 (en) | 2023-04-20 |
Family
ID=85987785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3235264A Pending CA3235264A1 (en) | 2021-10-13 | 2022-10-13 | Trem compositions and methods of use |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240401047A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4416288A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024538097A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240107319A (cg-RX-API-DMAC7.html) |
| CN (1) | CN120418430A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022362286A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3235264A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL311867A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024004568A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202325313A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023064513A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025080866A1 (en) * | 2023-10-10 | 2025-04-17 | Hc Bioscience, Inc. | Trna therapeutics for hemophilia |
| CN117805381B (zh) * | 2024-02-29 | 2024-05-28 | 首都医科大学附属北京积水潭医院 | 检测Gasdermin蛋白家族的物质在制备检测骨肉瘤的产品中的应用 |
| WO2026073261A1 (en) * | 2024-09-30 | 2026-04-02 | Flagship Pioneering Innovations Vi, Llc | Lipid nanoparticle formulations of trems |
| WO2026080471A2 (en) * | 2024-10-07 | 2026-04-16 | Flagship Pioneering Innovations Vi, Llc | Compositions of trem conjugates and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5679147B2 (ja) * | 2008-02-07 | 2015-03-04 | 独立行政法人理化学研究所 | 非天然塩基を含む改変tRNA及びその用途 |
| WO2020069194A1 (en) * | 2018-09-26 | 2020-04-02 | Case Western Reserve University | Methods and compositions for treating a premature stop codon-mediated disorder |
| JP2022534988A (ja) * | 2019-05-31 | 2022-08-04 | フラッグシップ パイオニアリング, インコーポレイテッド | tRNAプールを調節するためのTREMの使用 |
| JP7712270B2 (ja) * | 2019-11-01 | 2025-07-23 | テバード バイオサイエンシズ インコーポレイテッド | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
| WO2021142343A1 (en) * | 2020-01-09 | 2021-07-15 | The Regents Of The University Of California | Targeting transfer rna for the suppression of nonsense mutations in messenger rna |
| BR112022020780A2 (pt) * | 2020-04-14 | 2022-11-29 | Flagship Pioneering Innovations Vi Llc | Composições de trem e usos das mesmas |
| US20230203510A1 (en) * | 2020-05-29 | 2023-06-29 | Flagship Pioneering Innovations Vi, Llc | Trem compositions and methods relating thereto |
| KR20230135585A (ko) * | 2020-12-23 | 2023-09-25 | 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 | 변형된 trem의 조성물 및 이의 용도 |
-
2022
- 2022-10-13 CA CA3235264A patent/CA3235264A1/en active Pending
- 2022-10-13 JP JP2024522280A patent/JP2024538097A/ja active Pending
- 2022-10-13 CN CN202280082783.5A patent/CN120418430A/zh active Pending
- 2022-10-13 KR KR1020247015828A patent/KR20240107319A/ko active Pending
- 2022-10-13 EP EP22818139.2A patent/EP4416288A2/en active Pending
- 2022-10-13 MX MX2024004568A patent/MX2024004568A/es unknown
- 2022-10-13 AU AU2022362286A patent/AU2022362286A1/en active Pending
- 2022-10-13 TW TW111138921A patent/TW202325313A/zh unknown
- 2022-10-13 WO PCT/US2022/046632 patent/WO2023064513A2/en not_active Ceased
- 2022-10-13 IL IL311867A patent/IL311867A/en unknown
- 2022-10-13 US US18/700,523 patent/US20240401047A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240401047A1 (en) | 2024-12-05 |
| AU2022362286A1 (en) | 2024-05-02 |
| TW202325313A (zh) | 2023-07-01 |
| MX2024004568A (es) | 2024-06-28 |
| WO2023064513A9 (en) | 2024-08-02 |
| JP2024538097A (ja) | 2024-10-18 |
| WO2023064513A3 (en) | 2023-06-15 |
| KR20240107319A (ko) | 2024-07-09 |
| CN120418430A (zh) | 2025-08-01 |
| WO2023064513A2 (en) | 2023-04-20 |
| EP4416288A2 (en) | 2024-08-21 |
| IL311867A (en) | 2024-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230203510A1 (en) | Trem compositions and methods relating thereto | |
| US20240401047A1 (en) | Trem compositions and methods of use | |
| US20250340907A1 (en) | Methods and compositions for modulating a genome | |
| AU2017268397B2 (en) | Polynucleotides encoding interleukin-12 (IL12) and uses thereof | |
| ES2539188T3 (es) | Complejos de ARN y péptidos catiónicos para transfección e inmunoestimulación | |
| CN110719954B (zh) | 用于iii型糖原贮积病的治疗剂 | |
| US20180258123A1 (en) | Suppressors of Premature Termination Codons as Therapeutics and Methods for Their Use | |
| BR112019015797A2 (pt) | Composições de mrna terapêuticas imunomoduladoras que codificam peptídeos de mutação de oncogene de ativação | |
| WO2015048577A2 (en) | Crispr-related methods and compositions | |
| JP6158833B2 (ja) | ベータ−カテニン関連疾患を処置するための有機組成物 | |
| CA3214277A1 (en) | Ltr transposon compositions and methods | |
| WO2019143831A1 (en) | Compositions and methods for increasing expression of scn2a | |
| JP2024511437A (ja) | ポリヌクレオチド組成物、関連製剤、およびその使用方法 | |
| CA3241414A1 (en) | Nanoparticles and methods of production for the encapsulation of nucleic acids | |
| EP4514956A2 (en) | Compositions and methods for modulating a genome in t cells, induced pluripotent stem cells, and respiratory epithelial cells | |
| US20230203509A1 (en) | Trem compositions and methods relating thereto | |
| TW202507003A (zh) | Trem組合物及使用方法 | |
| US20250179492A1 (en) | Compositions of modified trems and uses thereof | |
| US20250313863A1 (en) | ENGINEERED CIRCULARIZED pegRNAs AND USES THEREOF | |
| WO2024035952A1 (en) | Methods and compositions for modulating splicing at alternative splice sites | |
| AU2024255972A1 (en) | Modified trems, compositions, and related methods thereof | |
| EA052416B1 (ru) | КОМПОЗИЦИИ мРНК ДЛЯ ВНЕПЕЧЕНОЧНОЙ ДОСТАВКИ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20240717 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250313 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251003 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251003 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20260206 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20260206 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-P146 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: BSL VERIFIED - NO DEFECTS Effective date: 20260209 |